Annuaire des statistiques sanitaires, vol.147, 2012. ,
Drug resistance in malaria. Chamblee, GA: Malaria Epidemiology Branch Centers for Disease Control and Prevention, 2001. ,
, Malaria control today: current WHO recommendations. Geneva: World Health Organization, 2005.
Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria, Parasitol Today, vol.12, pp.399-401, 1996. ,
Effects of artemisinin derivatives on malaria transmissibility, Lancet, vol.347, pp.1654-1662, 1996. ,
, Guidelines for the treatment of malaria, 2011.
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal, Malar J, vol.6, p.80, 2006. ,
A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali, Am J Trop Med Hyg, vol.79, pp.655-61, 2008. ,
Efficacy of non-artemisinin-and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon, Malar J, vol.9, p.56, 2010. ,
, The status of drug-resistant malaria along the Thailand-Myanmar border
Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study, Lancet Infect Dis, vol.15, pp.683-91, 2015. ,
, Geneva: World Health Organization, WHO. World malaria report, 2012.
, Methods for surveillance of antimalarial drug efficacy. Geneva: World Health Organization, 2009.
The impact of the expansion of urban vegetable farming on malaria transmission in major cities of Benin, Parasit Vectors, vol.3, p.118, 2010. ,
, WHO/Communicable diseases cluster. Severe falciparum malaria, Trans R Soc Trop Med Hyg, vol.94, pp.1-90, 2000.
, Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva: World Health Organization, 2003.
, Malaria fact sheet No. 94. Geneva: World Health Organization, 1996.
The use of genotyping in anti-malarial clinical trials: a systematic review of published studies from 1995-2005, Malar J, vol.5, p.122, 2006. ,
, Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. Geneva: World Health Organization, 2008.
Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand, Trans R Soc Trop Med Hyg, vol.93, pp.369-77, 1999. ,
Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in Northern Benin, Malar J, vol.12, p.413, 2013. ,
Effectiveness of artesunate-amodiaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non-inferiority randomised trial, Trop Med Int Health, vol.19, pp.469-75, 2014. ,
, Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. Geneva: World Health Organization, p.2007, 2007.
Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern Tanzania, Malar J, vol.13, p.376, 2014. ,
Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia, Malar J, vol.13, p.430, 2014. ,
Essai clinique randomisé comparant l'efficacité et la tolérance de la combinaison Artémisinine-Naphthoquine ,
, Coartem ® ) dans le traitement du paludisme simple au Bénin, vol.105, pp.208-222, 2012.
Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial, Lancet, vol.372, pp.1819-1846, 2008. ,
Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane ® ) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia, Malar J, vol.5, p.75, 2006. ,
Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial, Clin Infect Dis, vol.52, pp.873-82, 2011. ,
Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area, Malar J, vol.10, p.231, 2011. ,
Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial, Malar J, vol.13, p.9, 2014. ,
Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children, Malar J, vol.10, p.50, 2011. ,
Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Malar J, vol.14, p.325, 2015. ,
Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impact, Am J Trop Med Hyg, vol.87, pp.50-56, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01307775
Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria, Antimicrob Agents Chemother, vol.44, pp.697-704, 2000. ,
, Product monograph, 2010.
Efficacité de combinaisons thérapeutiques avec des dérivés de l'artémisinine dans le traitement de l'accès palustre non-compliqué au Burundi, Trop Med Int Health, vol.9, pp.673-682, 2004. ,
Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia. Malar J, vol.12, p.250, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00854378
Therapeutic efficacy of artemether/lumefantrine (Coartem ® ) against Plasmodium falciparum in Kersa, South West Ethiopia. Parasit Vectors, vol.3, p.1, 2010. ,
Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial, Malar J, vol.11, p.416, 2012. ,
efficacité et tolérance de l'association artemether lumefantrine dans le traitement du paludisme simple à Plasmodium falciparum au Niger, J Rech Sci Univ Lomé), vol.14, pp.79-84, 2012. ,
Early variations in Plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance, Malar J, vol.22, p.335, 2010. ,
, WHO. Global Malaria Programme. Status report on artemisinin resistance. Geneva: World Health Organization, 2014.
Coartem ® : the journey to the clinic, Malar J, vol.8, issue.1, p.3, 2009. ,
Artesunate-amodiaquine efficacy in Congolese children with acute uncomplicated falciparum malaria in Brazzaville, Malar J, vol.12, p.53, 2013. ,